Skip to content
CheckOrphan
  • Home
  • About Us
  • Log In
  • News
    • All News
    • Finance
    • Treatment
    • People
    • Research
  • Videos
  • Treatments
  • Clinical Trials
  • Access Programs
    • About Access Programs
  • Diseases
  • Events
  • Networks
  • Research
Main Menu

Subscribe for Free Newsletter

Email *

Type *

* Required Field
Email Marketing Services by Benchmark

Generate RSS

  1. Home
  2. /
  3. Clinical Trial
  4. /
  5. Auranofin for Giardia Protozoa

Auranofin for Giardia Protozoa

May 27, 2020checkorphan
Learn more about:
Amebiasis
Related Clinical Trial
Auranofin PK Following Oral Dose Administration Ameparomo Capsules 250 mg Drug Use Investigation Auranofin for Giardia Protozoa Anaemetro I.V. Infusion 500mg Drug Use Investigation Study of Nitazoxanide in the Treatment of Amebiasis in Adults and Adolescents Study of Nitazoxanide in the Treatment of Amebiasis in Children

Recruitment Information

Administrative Informations

Related Clinical Trial

  • Auranofin PK Following Oral Dose Administration
  • Ameparomo Capsules 250 mg Drug Use Investigation
  • Anaemetro I.V. Infusion 500mg Drug Use Investigation
  • Study of Nitazoxanide in the Treatment of Amebiasis in Adults and Adol
  • Study of Nitazoxanide in the Treatment of Amebiasis in Children
More Clinical Trial

Related Treatment

  • Miltefosine
  • Auranofin
  • Tinidazole
More Treatment

Related

  • Auranofin PK Following Oral Dose Administration
  • Ameparomo Capsules 250 mg Drug Use Investigation
  • Anaemetro I.V. Infusion 500mg Drug Use Investigation
  • Study of Nitazoxanide in the Treatment of Amebiasis in Children
  • Study of Nitazoxanide in the Treatment of Amebiasis in Adults and Adol
  • Miltefosine
  • Auranofin
  • Tinidazole
  • Amebiasis
More
pw

About CheckOrphan

CheckOrphan is a non-profit organization located in Basel, Switzerland and Santa Cruz, California that is dedicated to rare, orphan and neglected diseases. CheckOrphan offers users an interactive and dynamic platform for all these diseases. This strategy allows visitors to be updated daily on all the latest news and interact with people internationally. This is essential, because due to the nature of these diseases, there is not a large concentration of individuals within any given proximity.
Click here to know more About Us

Your email is important to us

Each email is sent to a CheckOrphan staff member and will be answered. We only use a contact form to avoid spam.

    Copyright © 2024 CheckOrphan.
    Developed by: Gonza.io logo Developed by: WebOptimalSolutions Powered by: Cloudscale logo